ABBV vs MRK
AbbVie Inc · Merck & Company Inc
Relative return (rebased to 100)
Key stats
| Metric | ABBV | MRK |
|---|---|---|
| Price | $285.64 | $145.27 |
| Market Cap | $504.76B | $358.41B |
| P/E | 119.44 | 19.63 |
| P/B | — | 8.55 |
| P/S | 8.25 | 5.51 |
| ROE | — | 43.5% |
| Net Margin | 6.9% | 28.1% |
| Gross Margin | — | — |
| Revenue Growth | 8.6% | 1.3% |
| Dividend Yield | 2.33% | 2.26% |
| EPS | $2.39 | $7.40 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.